Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials
- 10 November 2020
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 396 (10263), 1637-1643
- https://doi.org/10.1016/s0140-6736(20)32332-1
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Statins for Prevention of Cardiovascular Disease in AdultsJAMA, 2016
- The Impact of the Aging Population on Coronary Heart Disease in the United StatesThe American Journal of Medicine, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Conducting Meta-Analyses inRwith themetaforPackageJournal of Statistical Software, 2010
- Statins for Secondary Prevention in Elderly Patients: A Hierarchical Bayesian Meta-AnalysisJournal of Invasive Cardiology, 2008
- Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary AtherosclerosisJAMA, 2007
- Lipid-Lowering Therapy With Statins in High-Risk Elderly PatientsJAMA, 2004
- A refined method for the meta‐analysis of controlled clinical trials with binary outcomeStatistics in Medicine, 2001
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997